The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant deterioration in core profitability and earnings quality. Despite a reasonable current ratio and moderate debt/equity, the company is reporting negative profit and operating margins (-4.66% and -43.73% respectively), alongside a year-over-year revenue decline of 12.40%, which severely undermines its valuation. Although the stock trades below its 52-week high and has a modest dividend yield of 1.93%, the technical trend is deeply bearish (0/100), and analyst consensus is a hold with a target price below current levels. The combination of deteriorating fundamentals, poor earnings predictability, and lackluster price performance over the past three years supports a bearish outlook.